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Purpose: To present a biomathematical model based on the dynamics of cell populations to predict
the tolerability/intolerability of mucosal toxicity in head-and-neck radiotherapy. 
Methods and Materials: Our model is based on the dynamics of proliferative and functional cells
populations in irradiated mucosa, and incorporates the three A’s: Accelerated proliferation, loss of
Asymmetric  proliferation,  Abortive  divisions.  The  model  consist  of  a  set  of  delay  differential
equations,  and  tolerability  is  based  on  the  depletion  of  functional  cells  during  treatment.  We
calculate the sensitivity (sen) and specificity (spe) of the model in a dataset of 108 radiotherapy
schedules, and compare the results with those obtained with three phenomenological classification
models,  two based on a Biologically  Effective Dose (BED) function describing the tolerability
boundary (Fowler and Fenwick), and one based on an Equivalent Dose in 2 Gy-fractions (EQD2)
boundary (Strigari). We also perform a machine-learning-like cross-validation of all the models,
splitting the database in two, one for training and one for validation.
Results: When fitting our model to the whole dataset we obtain predictive values (sen+spe)  up  to
1.824. The predictive value of our model is very similar to that of the phenomenological models of
Fowler (1.785), Fenwick (1.806) and Strigari (1.774). When performing a  k=2 cross-validation, the
specificity and sensitivity in the validation dataset decrease for all models, from ~1.82 to ~1.55-
1.63. For Fowler the worsening is higher, down to 1.49.
Conclusions: Our model has proved useful to predict the tolerability/intolerability of a dataset of
108 schedules. As the model is more mechanistic that other available models, it could prove helpful
when designing unconventional dose fractionations, schedules not covered by datasets to which
phenomenological models of toxicity have been fitted.









Many clinical trials have tested non-conventional schedules to improve tumor control probability in
head-and-neck  cancer,  including  acceleration,  dose  escalation,  or  gaps  [1].  Intolerable  mucosal
toxicity is a limiting factor in dose escalation and/or treatment shortening in head-and-neck cancer
[2-4]. Finding the boundary separating tolerable and intolerable schedules is of particular interest,
especially when aiming at designing novel unconventional fractionation schedules.
Mathematical  models  have  been employed to tackle  this  problem.  Kaanders  et  at. [5]  initially
explored  this  issue,  and  by  plotting  the  total  dose  versus  the  treatment  time,  they  found  that
intolerable schedules tend to deliver larger doses over shorter times. Fowler  et al. [6], used the
linear-quadratic model to investigate the tolerable/intolerable boundary, and proposed a boundary
between  tolerable  and  intolerable  schedules  based  on  the  Biologically  Effective  Dose  (BED).
Fenwick et al. [7] developed that model, using delay-differential equations to obtain a novel BED
vs. treatment time formula that resulted in better separation of tolerable and intolerable schedules.
Strigari  et  al. [8]  tackled  this  problem by  employing  the  LKB formulation  of  Normal  Tissue
Complication Probability (NTCP). With their model, they achieved values of sensitivity/specificity
similar  to  [7],  while  at  the  same time predicting the level  of  severe  mucositis  NTCP of  those
schedules. More recently, machine learning techniques have been used to predict patient-wise the
probability of severe mucosal mucosal toxicity [9, 10, 11].
All  models  mentioned  above  are  phenomenological.  Mechanistic  models  can  add  to  our
understanding of  the processes  involved in  response to radiotherapy,  and may prove especially
useful  when  designing unconventional  dose  fractionations.  In  this  work  we  present  a  more
mechanistic approach to the problem, based on the three A’s of accelerated proliferation [12]: loss of
asymmetry, accelerated proliferation, and abortive divisions. We rely on the compartment model of
cell  population  dynamics  in  mucosa  presented  in  [13],  which  has  been  extended  to  multiple
fractions, including incomplete repair between fractions, and we link tolerability/intolerability of a
given schedule to the numbers of cell populations in the mucosa. Systems of differential equations
have previously been used to model dynamics of cell populations in normal tissues, including for
example toxicity [14] and cancer induction [15], tumor reoxygenation [16] or response to molecular
radiotherapy [17, 18]. We validate our model in an extended dataset of tolerability/intolerability of










2. Methods and Materials
2.1. Model of dynamics of cell populations
The model presented in [13] for single fraction irradiation has been extended to multiple fractions.
We  refer  the  reader  to  that  publication  for  a  detailed  presentation  and  study  of  the  model’s
description of cell dynamics in preclinical data of cell. We initially assume two compartments of
cells:  proliferative  cells  (SC),  and  fully  differentiated,  non-proliferative,  functional  cells  (FC).
Proliferation is  controlled by the fraction of proliferating cells,  p,  the division time,  τ,  and the
asymmetry factor AF (the fraction of SCs arising from a cell division, in equilibrium, each division
will produce one SC and one FC, and  AF=0.5). Irradiation will generate a new compartment of
cells, containing SCs that have been lethally damaged by radiation and are doomed. Cells in this
compartment still carry some proliferative capacity (abortive divisions), but will eventually die and
disappear with a death rate,  γA. FCs are non-proliferative and insensitive to radiation, but are lost
due to natural turnover (rate μ). A graphical sketch of the model is presented in Figure 1.
The set of delay differential equations describing the evolution of these three populations of cells
during a radiotherapy treatment is as follows:
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=
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(3)
γA and γS are the death rate of abortive and undamaged stem cells, respectively. The term SF(t) is the
surviving  fraction  of  irradiated  cells,  and  accounts  for  the  transfer  of  cells  from  the  healthy
compartment, S,  to  the doomed compartment,  SA,  when a radiation fraction is  applied.  d(t) the
applied dose at time  t, which is zero when  t is not in {tD}, the vector of irradiation times. The
delivery of each fraction is considered to be instantaneous, hence the formal introduction of the
Dirac delta function in the equations. If time between fractions is low, as can happen in schedules









Therefore,  the  surviving  fraction  has  been modeled  with  the  linear-quadratic  (LQ)  model  with
incomplete repair correction [19, 20]. The surviving fraction of cells following the k-th radiation










θq=exp(−ν Δ t q) ; Δ t q=t q +1−t q (5)
αd and βd are the LQ parameters characterizing cell radiosensitivity, and ν is the repair rate of sub-
lethal damage.
AF and p describe the asymmetry factor and proliferative fraction via:
AF ( t ) =
S (t ) +SA ( t )
S0 (6)
p ( t ) =max ( p0 ,1− (1− p0) [ F ( t )F0 ])
(7)
where S0 and F0 are numbers of proliferative and functional cells cells in the steady state. According
to this  functional  form, when an external  perturbation (radiation)  kills  a  substantial  fraction of
proliferative cells, the remaining proliferative cells will adapt and try to recover by decreasing AF
(loss of asymmetry). This shortage of proliferative cells will lead to a shortage of functional cells
because tissue turnover cannot be compensated. Loss of functional cells will trigger an increase in
the fraction of proliferative cells undergoing division (accelerated proliferation). In Eq. (7) p0 is the
steady proliferation fraction, which can be determined from the steady state condition (dF/dt=0) to
be p0=μτF0/(S0 exp(-γSτ)).
2.2. Intolerable/Tolerable mucositis model








schedule  according  to  the  population  of  functional  cells.  Our  tolerability  criteria  rely  on  the
requirement that functional cells maintain the functionality of the tissue, and their elimination may
trigger  toxicity,  while  proliferating  cells  contribute  to  maintain  intended  cell  densities.  While
toxicity is a complex phenomenon, which depends on more factors than the number of cells, in
rapidly turning-over tissues the number of cells is bound to play an important role [21-23].
We have investigated two simple criteria (Figure 1): first, we consider a schedule to be intolerable if
the  number  of  functional  cells  falls  below  a  given  threshold  (Fth),  relative  to  the  steady-state
population of cells (Criterion 1):
Criterion1={intolerable , if F≤F thtolerable , otherwise (8)
Secondly, we consider that if the number of functional cells remains below the threshold longer than
a time tth, the schedule will be intolerable  (Criterion 2):
Criterion2={intolerable , if F≤F th for a length time t≥t thtolerable ,   otherwise (9)
2.3. Comparison with other classification models
Our model has been compared with three phenomenological models presented in references [6-8],
which  we  will  refer  to  as  Fowler,  Fenwick,  and  Strigari.  These  models  are  based  on  a  BED
boundary  between  tolerable/intolerable  schedules,  and  they  are  presented  in  the  detail  in  an
Appendix.
2.4. Experimental dataset
We  have  tested  our  model  on  an  extended  dataset  cataloging  the  tolerability/intolerability  of
radiation mucositis induced by different head-and-neck radiotherapy schedules, which builds upon
schedules provided in [6-8], while also adding some further schedules. As in our model we need not








we have reviewed each original article to find the necessary data. If times of dose delivery could
easily be inferred from available data, such schedules were incorporated to the dataset, otherwise
they were left out. In many cases,   elements of the radiation schedule such as  duration, gaps and
doses  varied  among the  studied  population,  and we considered  median  values  if  reported.  For
accelerated schedules delivering several doses per day, a separation of 6 h between doses given in
the same day was considered when not explicitly stated in the reference.
Some very low dose, tolerable schedules used in [6-8] were left out of the analysis, because in these
cases  tolerability  is  not  an issue.  These  schedules  typically  correspond to the  first  part  of  gap
treatments, when toxicity is evaluated and treatment continued if acceptable (schedules 77 to 84 in
Table A1.1 in [7]). Nonetheless, they are included in a dataset available as Supplementary Materials
in openoffice spreadsheet format in order to provide the most complete picture.
In some cases, the tolerability of a schedule is disputable. There are four such schedules in our
dataset (Table A.1.2. in Ref [7]). These schedules are reported as “disputable” in our dataset, but for
fitting  purposes,  we  have  considered  K11  (“Program  is  not  doable  outside  the  experimental
protocol”) and F31 (“… may necessitate lowering the dose ...”) as intolerable, and K41/F8 (“Acute
toxicity  does  not  represent  a  major  obstacle”)  and F28 (“Toxicity  is  high  but  manageable”)  as
tolerable.
The dataset contains data for 108 radiotherapy schedules (plus 8 additional tolerable schedules that
correspond to the first part of gap treatments that have not been used in the analysis, as discussed
above), of which 15 were deemed intolerable (13.9%), a fraction similar to that reported in [7] (84
schedules, 13 intolerable, 15.5%), and [8] (107 schedules).
2.5. Numerical implementation, optimization and parameters
The set of differential equations is coded in Matlab (The Mathworks Inc.), and solved by employing
an Euler method [24], with a time step of 1 hour. The classification models presented in [6-8] were
also implemented. A simulated annealing algorithm [13, 25] was implemented for the optimization
problem (model fitting to the experimental dataset). This methodology seems appropriate for the
problem  under  study,  where  gradient-descent  methods  may  be  suboptimal  due  to  local









C, to be maximized is defined as the sum of sensitivity (sen) and specificity (spe),
C = sen + spe (14)
where the sensitivity is defined as the number of true positives (TP) over positive cases (P), and the







Positives  are  defined  as  intolerable  schedules,  and  TP  as  schedules  correctly  classified  as
intolerable,  while  negatives  are  defined  as  tolerable  schedules,  and  TN  as  schedules  correctly
classified as tolerable. We use such an objective function in order to give equal weight to tolerable
and intolerable schedules, even if the number of intolerable schedules in the dataset is much lower
than the number of tolerable ones. Other optimization criteria, like minimizing the number of miss-
classifications (either tolerable or intolerable) would not be convenient as they would undervalue
the importance of correct classification  of intolerable schedules.
We have fixed the values of αd/βd=10 Gy (as typically done for mucositis [12]), and the incomplete
repair parameter, T1/2=3.2 h as in [7, 26] (ν=log(2)/T1/2 = 0.2166 h-1). The BED-model of Fowler has
three free fitting parameters, αdTd, Tk and BED0, while the BED-model of Fenwick and TD50-model
have two free parameters each, BED0 and Tc, and TD50(0) and Δ, respectively. These free parameters
have been fitted to maximize the cost function  C defined in the previous section. The number of
free parameters in our model is larger, 6-7 parameters, namely, αd, τ, γA (we take γS=0), μ, the fraction
of functional cells, fF (the percentage of proliferating cells is fS=1-fF), and Fth and tth (the parameters
of the tolerability model). In order to reduce the number of free parameters in our model, we have
fixed αd=0.1 Gy-1 and τ=48 h. These parameters have not been as frequently studied experimentally
or used in models, especially in clinical studies. Our approach has been to set round values within
ranges reported in the literature. For the proliferation time τ, Dörr and colleagues have reported
values ranging from ~1 day to ~4 days ([27, 12] and references therein). We have picked a value in
this range, 2 days. This value would also approximately match the proliferation needed to counter a
turnover time of 4 days (in the range reported for those tissues) if ~50% of the cells are proliferative








αd (~0.02-0.05 Gy-1), yet values typically reported in clonogenic studies tend to be higher, ~0.2-0.3
Gy-1. Therefore, we have opted for selecting a relatively low value for  αd, yet not as low as some
reported values.
2.6. Model validation, parameter stability, and cross-validation
First,  we have investigated the performance of our model  (with two classification criteria)  and
models reported in references [6-8] (equations A1-4) on the whole dataset.  Several optimizations
were  run  in  order  to  avoid  convergence  to  local  maxima.  Once  best-fitting  parameters  were
obtained, the stability of the solution around those parameters was evaluated, in order to provide an
estimation of the uncertainties of best fitting parameters. Random perturbations were applied to the
set of best-fitting parameters, the value of the objective function evaluated, and the combination of
parameters  saved  if  the  value  of  the  objective  function  did  not  change  (until  reaching  100
combinations). The dispersion of parameters was then analyzed.
Secondly, we investigated the cross-validation of all the models studied: the performance of the
model,  with  optimal  parameters  obtained  in  a  training  dataset,  on  an  independent  validation
dataset.  In  order  to  do  so,  and  due  to  the  lack  of  several  large  datasets,  we  have  used  the
methodology of  stratified k-fold cross-validation [28]: our dataset has been split in two datasets
(k=2), training and validation; each schedule is randomly included in one or another dataset (50%
probability); model parameters are optimized in the training dataset; and the model with those same
parameters is used on the validation dataset, and the sensitivity and specificity are calculated; this
procedure is repeated 20 times (with different training/validation datasets) to check the consistency
of the results.  Due to the relatively low number of intolerable schedules,  the generation of the
training/validation datasets was stratified, imposing a constraint of at least 5 intolerable schedules in
every training/validation dataset.
3. Results
3.1. Parameter optimization and validation: whole dataset









we present sets of best-fitting parameters (that maximize the cost function), as well as achieved
values of sensitivity and specificity, for every single model.
We have observed through multiple optimizations that our models present maxima clustered around
two different sets of parameters for Criterion 1 and Criterion 2: the first configuration corresponds
to rapidly disappearing abortive cells (γA~0.04 h-1, corresponding to a half-life of ~17 h) and very
low values of  Fth to trigger intolerability (~2×10-3); the second cluster is associated with longer-
lived abortive cells (γA~0.007 h-1, corresponding to a half-life ~100 h) and much higher values of Fth
(~0.6). The turnover rate of functional cells μ is in the 0.005-0.011 h-1 range, which yields half-lives
for such cells of ~60-140 h, within the range of typically reported 4 days  [21].
Classification criterion  1 can  reach  sensitivity  and  specificity  values  of  93.3%  and  83.9%,
respectively (C=1.772), while criterion 2, which incorporates an extra free parameter can improve
the value of the cost function to C=1.824.
In  Figure  2  we  show  the  evolution  of  the  population  of  cells  during  treatment  for  three
representative types of schedules in our database, a conventional 35×2 Gy-7 weeks schedule, an
accelerated 68×1.2 Gy-2 fracs/day schedule, and an accelerated+gap schedule. The depletion during
treatment  and subsequent  repopulation  of  the proliferative and functional  compartments can be
qualitatively appreciated, together with the appearance and elimination of doomed cells after some
abortive divisions. In Figure 3 we present histograms of the populations of functional cells, split in
tolerable and intolerable schedules (classification criterion 1).
The predictive value of our models is similar to that of models presented in [6-8] (Table 1). When
using the  Fowler model  (equation  A1) to  analyze the whole  dataset,  we obtain sensitivity  and
specificity values of 100% and 78.5% (C=1.785); with  Fenwick model (equation A2) we obtain
sensitivity  and specificity  values  of  100.% and 80.6% (C=1.806);  and with  the  Strigari model
(equation  A4),  100.0%  and  77.4%  (C=1.774),  respectively.  In  Figure  4  we  show  the
tolerability/intolerability boundary obtained with Fowler, Fenwick, and Strigari models.
In Figure 5 we present a study of the uncertainties of the best-fitting parameters and stability of the
solution  under  perturbations  of  parameters,  as  described  in  section  2.6.  The  figure  shows
correlations between different parameters, with different values leading to the same value of the









algorithm (reported  in  Table  1)  are  stable  under  relative  perturbations  of  ~0.2-1% for  Fowler,
Fenwick and  Strigari , ~1-2% for  classification criterion 1. On the other hand, the best solution
obtained with  criterion 2, which is the best solution among all models, is extremely sensitive to
perturbations  of  parameters,  and  variations  <0.02% for  any  parameter  other  than  tth lead  to  a
worsening of the solution.
3.2. Cross-validation
When we performed a cross-calibration of our model by splitting the dataset in two sets, one for
training  one  for  validation,  for  all  models  the  specificity  and  sensitivity  of  classification  of
tolerability in the validation dataset were lower than in the training dataset, and this was particularly
the case for Fowler model. In Table 2 we report mean values and standard deviation for 20 cross-
validations (with different randomly generated training/validation datasets).
Average sensitivity and specificity values are 95-99% and 83-87%, respectively, for the training
dataset, falling to 72-84% and 79-83% for the validation dataset for all models except Fowler’s,
with  large  standard  variations  (up  to  20%)  for  sensitivity  in  the  validation  dataset.  C-values
(sen+spe) decrease from ~1.82 for the training datasets to ~1.55-1.63 for the validation datasets.
The performance of Fowler model in the validation datasets is notably less good, with sensitivity
and specificity values around 68% and 81%, respectively, and C~1.49.
4. Discussion
Mucosal toxicity is a limiting factor in dose escalation and/or treatment shortening in head-and-
neck cancer. Predicting the tolerability or intolerability of a given radiotherapy schedule can help
the design of novel radiotherapy treatments, aiming at maximizing tumor control while keeping
toxicity under control. Different mathematical models have been introduced to tackle this issue. In
this  work  we  present  a  novel  model,  based  on  population  dynamics  of  cells,  which  is  more
mechanistic  than  other  purely  phenomenological  models.  Our  model  has  been used  to  classify
tolerable/intolerable schedules in a dataset comprising 108 schedules, and its performance has been
compared with three classification models based on BED and EQD2, developed by Fowler  et al.









Remarkably, our models can match the predictive power of classical phenomenological models.
After an optimization aiming at maximizing  the sum of sensitivity and specificity on the whole
dataset, we have obtained similar values of sensitivity and specificity for our models (sen=93.3%,
spe=83.9%, criterion 1; sen=93.3%, spe=88.2%, criterion 2) and the other three models under study
(sen=100.0% and spe=77.4%,  Fowler;  sen=100.0% spe=80.6%,  Fenwick;  and  sen=100.0% and
spe=77.4%, Strigari). The values of the objective function, C=sen+spe, are very similar for the five
models studied: 1.772 (criterion 1), 1.824 (criterion 2), 1.785 (Fowler), 1.806 (Fenwick) and 1.774
(Strigari).
On the other hand, sensitivity and specificity are always overrated when the model is evaluated on
the dataset used to optimize its performance. But, after performing a cross-validation of our model,
in which the model is trained on half of the dataset (on average), and validated on the other half, we
have found reasonable values of sensitivity and specificity on the validation dataset (around 80%
and 82% for criterion 1). This demonstrates that the good performance of the model is not due to
overfitting in the (training) dataset, as predictive power is still good in a different dataset, and shows
that  the  model  is  reliable  for  the  classification  of  tolerable/intolerable  schedules.  Interestingly,
results are somewhat worse with criterion 2 in the validation dataset, which may be caused by the
extra free-parameter causing overfitting in the training dataset. The same cross-validation procedure
was applied to  Strigari,  Fenwick,  and  Fowler models.  The first  two models  also maintain  fair
predictive  power  when  applied  to  the  validation  dataset.  However,  Fowler model  had  limited
success  in  correctly  classifying  intolerable  schedules  in  the  validation  dataset  (sen~68%).  This
limitation may result from both the rather small number of intolerable schedules in the dataset,
which can cause the training and validation cohorts  to contain very different information about
intolerable schedules, and the greater degree of flexibility of the  Fowler model, which has three
separate parameters controlling  the baseline tolerable BED, the rate at which this increases with
schedule duration and the critical duration beyond which the increase begins, compared to only two
parameters in the models of Fenwick and Strigari.
Like the models to which it  has been compared, our model aims at  separating population-wise
tolerable  and  intolerable  schedules.  While  this  is  important,  for  example  when  designing  new
fractionations, certainly the optimal approach would be to develop methods that would allow to
predict the risk of intolerable toxicity of each individual patient,  based on their dose-distribution,








potentially permits some individualization by linking model parameters such as radiosensitivity and
proliferation capacity, cell turnover to genetic profiling [29, 30].
A limitation of our model arises from its compartment-model nature: the model does not include
spatial  dimensions,  and therefore  cannot  directly  account  for  dose-volume or  dose-area  effects,
including repopulation by cell migration from undamaged tissue. This limitation does not allow to
incorporate into the model complex individualized dose distributions in mucosa, as can be done in
some NTCP-based methods [9, 10]. Spatial dimensions could be added to the model, transforming
it in a spatio-temporal model. Such model would be a more accurate representation of the mucosa,
but also rather more complex. With the good results obtained with the current method, it is doubtful
that such spatio-temporal models would improve obtained sensitivity/specificity, but it is an issue
worth investigating, as a model of that kind would allow to simulate the effect of dose distribution
heterogeneities on the response of the mucosa. Certainly, the added complexity of such a model
would probably only be worthwhile if it was used to fit data including spatial information.
Our model relies on the underlying description of fractionation effects provided by the LQ model.
The validity of the LQ model has been questioned, especially when delivering large radiation doses,
and some alternatives have been suggested [31, 32]. Those models could be easily implemented in
our  model,  but  given that  highly hypofractionated schedules  are  rarely  used for  head-and-neck
radiotherapy, using the LQ model seems to be well reasonable.
An  interesting  approach  would  be  to  develop  and  apply  a  similar  model  to  chemo-irradiation
treatments, which have been investigated by Meade et al. [33] using the models presented in [6-8].
In  our  model,  chemotherapy  could  be  introduced  through  a  new  term  of  cell  death  in  the
proliferative compartment,  thereby limiting repopulation of both the proliferative and functional
compartments.
In general, the success of phenomenological models (in particular Fenwick and Strigari models) in
predicting the tolerability of different radiotherapy schedules in head-and-neck cancer (including
cross-calibration),  and their  simplicity,  should  make them preferable over  complex mechanistic
models in the clinic. However, mechanistic models can still usefully add to our understanding of










Our  model  has  proved  useful  to  predict  the  tolerability/intolerability  different  radiotherapy
schedules on a dataset of 108 schedules, achieving sensitivity/specificity values similar to those
obtained using other models (Fowler, Fenwick and Strigari). 
Mechanistic models can clarify our understanding of the processes involved in  the response to
radiotherapy,  and  our  approach  may  prove  helpful  when  designing  unconventional  dose
fractionations delivering differing doses per week/day, the tolerability of such schedules not being
described by the datasets to which phenomenological models of toxicity have been fitted. However,
Fenwick and  Strigari models  can  classify  tolerable/intolerable  schedules  as  well  as  the  more
mechanistically based models presented in this work, and their relative simplicity may facilitate
their use in the clinic. 
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Appendix: Classification models of Fowler, Fenwick, and Strigari
Fowler: 
In  [6],  the  boundary  between  tolerable/intolerable  radiotherapy  schedules  was  modeled  with  a
simple hockey-stick BED function:
BEDboundary (T )=BED0+ log (2)
(T −T k)
αT p (A1)
where Tk is the accelerated proliferation kick-off time, and Tp the doubling time of stem cells in the
mucosa. 
Fenwick: 










BED boundary (T )={
BED0 [ TT c ]/sin (
T
T c ) , if T≤Tc
BED0 [ TTc ] , if T>T c
(A2)
In the above equations T is the treatment time (in days), including the first day of treatment, and the
argument of the sine term is expressed in radians. If the BED of a given schedule is above the
boundary, it is classified as intolerable, while if it is below the boundary, it is classified as tolerable.





























Here, Δtk is the time between fraction k and k+1, and T1/2 is the repair half-time.
Strigari:
In [8], the authors used a TD50 boundary, in units of EQD2, equivalent dose in 2 Gy fractions
TD50 (T )=TD50 (0)exp((T −5)/Δ) (A4)
where T is again the treatment time, and TD50(0) and Δ are fitting parameters. If the EQD2 of a given
schedule is below the boundary, it is classified as tolerable, otherwise it is intolerable.  The EQD2 is
computed from the BED as EQD2=BED/(1+2/(αd/βd)),  and also includes the effect of incomplete
repair.
Data availability 
The data used for this study is provided in a supplementary spreadsheet. The code containing the
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Figure captions
Figure 1: Sketch of the model of cell dynamics of stem cells (S), abortive cells (SA) and functional
cells (F) (left), and the criteria for toxicity evaluation (right).
Figure 2: Dynamics of populations of cells versus time for three different treatments in our dataset:
a conventional 35×2 Gy-7 weeks treatment (solid blue line), an accelerated 68×1.2 Gy-2 fracs/day
treatment (dashed red line), and an accelerated+gap treatment, 42×1.6 Gy-2 fracs/day-15 days gap









doomed proliferative cells (center), and functional cells (right). These results have been obtained
with parameters presented in Table 1 (criterion 1).
Figure  3:  Histogram of  the  relative  minimum number  of  functional  cells  for  each  of  the  108
schedules in our dataset, split in intolerables (A) and tolerables (B).  The thick lines in both panels
represent the threshold Fth of tolerability. These results have been obtained with model parameters
presented in Table 1 (criterion 1).
Figure 4: BED versus treatment time for each schedule in the dataset. Intolerable schedules are
represented with crosses, and tolerable schedules with circles. Lines show the optimal boundaries
between  tolerable  and  intolerable  schedules  obtained  with  Fowler model  (dash  line),  Fenwick
model (solid line), and Strigari model (dash-dot line). Notice that EQD2 values from Strigari’s fit
have been converted to BED values.
Figure 5: Plots of different combinations of parameters (perturbations around values reported in
Table 1) that lead to the same value of the objective function for Fowler (A), Fenwick (B), Strigari
(C), and Criterion 1 (D). We also show relative standard deviations, σ, for each parameter. Notice
that only two parameters are shown in each panel, but Fowler and Criterion 1 have more degrees of
freedom.
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